FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology, and aims at prediction of Ewing sarcoma generalization in children. After the surgical stage of the treatment, the complex and combined therapy of Ewing's sarcoma is used to assess the expression of the ZEB-1 marker in the primary tumor tissue by immunohistochemistry. If the level of ZEB-1 is equal to 60% and more, generalization of the tumor process is predicted within 5 months.
EFFECT: invention allows predicting the generalization of the tumor process in Ewing's sarcoma in children at the surgical stage.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING TREATMENT RESULTS OF EMBRYONIC TUMOURS | 2021 |
|
RU2760168C1 |
| METHOD FOR CALCULATING THE PERIOD OF DISTANT METASTASIS IN PATIENTS WITH COLON CANCER AND RECTOSIGMOID JUNCTION | 2022 |
|
RU2782149C1 |
| METHOD OF PREDICTING PROCESS GENERALISATION IN CASE OF MALIGNANT BONE TUMOURS | 2010 |
|
RU2427323C1 |
| METHOD OF PROGNOSING GENERALIZATION OF PROCESS IN CHILDREN AND ADOLESCENTS WITH OSTEAL SARCOMA | 2004 |
|
RU2282195C2 |
| METHOD FOR PREDICTING MALIGNANT NEOPLASMS IN SMALL PELVIC ORGANS | 2004 |
|
RU2246259C1 |
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
| METHOD OF RADIONUCLIDE DIAGNOSIS OF LUNG CANCER | 2008 |
|
RU2397704C2 |
| METHOD OF DIAGNOSING TUMOUR PROCESS DISSEMINATION IN PATIENTS WITH NON-SMALL-CELL LUNG CARCINOMA | 2011 |
|
RU2454931C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CERVICAL CANCER IN PATIENTS WITH STAGE IIB | 2022 |
|
RU2789500C1 |
| METHOD OF INDIVIDUAL PRE-RADIATION PREPARATION OF PATIENTS SUFFERING FROM BREAST CANCER | 2008 |
|
RU2377020C1 |
